Debian LTS: DLA-3179-1: pixman security update | LinuxSecurity.com

- -------------------------------------------------------------------------
Debian LTS Advisory DLA-3179-1                [email protected]
https://www.debian.org/lts/security/                           Chris Lamb
November 07, 2022                             https://wiki.debian.org/LTS
- -------------------------------------------------------------------------

Package        : pixman
Version        : 0.36.0-1+deb10u1
CVE ID         : CVE-2022-44638
Debian Bug     : 1023427

It was discovered that there was a potential out-of-bounds write
vulnerability in pixman, a pixel-manipulation library used in many
Linux graphical applications.

For Debian 10 buster, this problem has been fixed in version
0.36.0-1+deb10u1.

We recommend that you upgrade your pixman packages.

For the detailed security status of pixman please refer to
its security tracker page at:
https://security-tracker.debian.org/tracker/pixman

Further information about Debian LTS security advisories, how to apply
these updates to your system and frequently asked questions can be
found at: https://wiki.debian.org/LTS

Debian LTS: DLA-3179-1: pixman security update

November 7, 2022
It was discovered that there was a potential out-of-bounds write vulnerability in pixman, a pixel-manipulation library used in many Linux graphical applications

Summary

For Debian 10 buster, this problem has been fixed in version
0.36.0-1+deb10u1.

We recommend that you upgrade your pixman packages.

For the detailed security status of pixman please refer to
its security tracker page at:
https://security-tracker.debian.org/tracker/pixman

Further information about Debian LTS security advisories, how to apply
these updates to your system and frequently asked questions can be
found at: https://wiki.debian.org/LTS


Severity
Package : pixman
Version : 0.36.0-1+deb10u1
CVE ID : CVE-2022-44638
Debian Bug : 1023427

We use cookies to provide and improve our services. By using our site, you consent to our Cookie Policy.